News

Isolation and characterisation of monoclonal antibodies from three convalescent COVID-19 patients

July 03, 2020

Share article

The authors describe their isolation of monoclonal antibodies from three convalescent COVID-19 patients using a SARS-CoV-2 stabilised pre-fusion spike protein. They found that these antibodies have low levels of somatic hypermutation and were very enriched in VH1-69, VH3-30-3 and VH1-24 gene usage. A subset of the antibodies were able to potently inhibit SARS-CoV-2 infection at levels as low as 0.007 μg/mL. Competition and electron microscopy studies found that the SARS-CoV-2 spike protein is made up of multiple distinct antigenic sites, including several receptor-binding domain (RBD) epitopes as well as non-RBD epitopes. Therefore these antibodies are promising therapeutic candidates and provide evidence for vaccine design.

Read more here

Brouwer PJM, Caniels TG, van der Straten K, Snitselaar JL, Aldon Y, et al. ISSN: Science; eabc5902

2020

Added: July 03, 2020